Where it comes from
- Made in
- Heart and blood: the predominant apelin found in human heart tissue
- Sent out by
- With the other apelins
- Acts on
- Heart muscle
- Vessels
- Kidney
What it does
- The pyroglutamate cap blocks the enzymes that chew peptides from the front, so it outlasts plain apelin-13 in blood 1
- The form actually present in human heart tissue, which is why it, and not apelin-13, is what infusion studies use 1
- At the receptor it behaves as apelin-13 does: vessel relaxation through the endothelium, and a stronger, faster heartbeat 2
In medicine
- Infused in healthy volunteers and in patients with heart failure as a research probe, where it raised cardiac output and lowered systemic resistance within minutes 2
- No approved medicine and no clinical assay. Commercial apelin kits do not report the isoforms separately, so a published apelin level is a mixture 1
Beyond the body’s own use
- Its discovery changed what counts as the real human apelin: the peptide most earlier work had used is not the one the heart mainly holds 1
- Analogues meant for the clinic start from this form because of its stability, and none has yet reached a registered trial
- Nothing is in human use beyond research infusions. How much of the apelin measured in blood is this form is still unknown 1
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.